Editorials represent the opinions EDITORIALS of the authors and THE JOURNAL and not those of the American Medical Association. Postmarketing Surveillance— Lack of Vigilance, Lack of Trust wonder that, in 2003, the pharmaceutical industry ear- Phil B. Fontanarosa, MD marked $4.9 million to lobby the FDA. Drummond Rennie, MD While these concerns are noteworthy, they pale in com- Catherine D. DeAngelis, MD, MPH parison to the shortcomings and failures of the current im- perfect system for postmarketing surveillance. This system is intended to detect adverse drug events and reactions once HYSICIANS AND PATIENTS EXPECT THAT WHEN MEDI- new products are in widespread use, and thereby limit ex- cations are prescribed correctly for labeled indica- posure of the public to hazards of new medications. The in- tions and are used as directed, these medications gen- adequacies of the postmarketing surveillance system (ie, Perally will have beneficial effects and will not cause FDA’s MedWatch program with passive collection of spon- significant harm. This confidence in pharmaceutical prod- taneous reports of adverse drug reactions) for ensuring safety ucts reflects trust in the effectiveness and integrity of the are well known and include: reliance on voluntary report- drug approval and monitoring process. ing
JAMA – American Medical Association
Published: Dec 1, 2004
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera